Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)
Market Currents

Jazz Pharmaceuticals (JAZZ) receives coverage from Piper Jaffray with an initial rating of...

  • Thursday, July 14, 2011, 8:28 AM ET
    Jazz Pharmaceuticals (JAZZ) receives coverage from Piper Jaffray with an initial rating of Overweight and a $51 price target. Shares +1.4% premarket.
LATEST|
TODAY SO FAR|
YESTERDAY
Other date
DJIA (DIA) S&P 500 (SPY)
Latest Articles
More Latest Articles »